Head and Neck Cancer Diagnostic Methods Market by Diagnostic Methods, End-user and Geography - Forecast and Analysis 2023-2027

Published: Sep 2023 Pages: 183 SKU: IRTNTR40322

Head and Neck Cancer Diagnostics Market 2023-2027

The global head and neck cancer diagnostics market size is estimated to grow by USD 4,937.16 million at a CAGR of 12.2% between 2022 and 2027. 

To control and fight cancer, private and government agencies have several initiatives that help to promote cancer awareness, diagnosis, and treatment. For example, the American Cancer Society, founded in 1913, works to reduce the risk of cancer. Its global health programs include global anti-cancer efforts, focused on preventing cancer, saving lives, and alleviating suffering. Furthermore, the existence of such initiatives that aim to address the global problem of cancer, rather than just covering a specific region, will promote acceptance of cancer diagnoses, including head and neck cancer, and In turn, will drive the growth of the market during the forecast period.

Technavio has segmented the market into Diagnostic Methods, End-user and Geography

  • The diagnostic methods segment includes biopsy and blood tests, imaging, endoscopy, and dental diagnostics
  • The end-user segment includes hospitals, specialty clinics, ambulatory surgical centers, and others
  • The geography segment includes key regions such as North America, Europe, Asia, and Rest of World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2017 to 2021, besides analyzing the current market scenario.

What will be the size of the Head and Neck Cancer Diagnostics Market During the Forecast Period?

To learn more about this report, Request Free Sample

Head and Neck Cancer Diagnostics Market Segmentation by Diagnostic Methods, End-user and Geography Analysis

Diagnostic Methods Analysis 

Biopsy and blood tests

The market share growth by the biopsy and blood tests segment will be significant during the forecast period. A biopsy is a laboratory procedure in which a piece of tissue or cell sample is removed for analysis in a laboratory. A biopsy is done to diagnose cancer. Biopsies to diagnose head and neck cancer include incisional biopsy, fine needle aspiration (FNA) biopsy, and human papillomavirus (HPV) testing.

Get a glance at the market contribution of various segments View a PDF Sample

The biopsy and blood tests segment was valued at USD 1,511.10 million in 2017. Blood tests to detect head and neck cancer include liver function tests (LFTs), cell counts, and measuring antibodies to Epstein-Barr virus (EBV). As biopsies and blood tests can be performed even after performing other diagnostic methods, this segment is expected to contribute the largest revenue share to the global head and neck cancer diagnostics market during the forecast period.

End-user Analysis

Hospitals

Head and neck cancer diagnostic products offer a variety of benefits to hospitals and clinics at different levels and in different roles, including driving cost savings by improving patient care and satisfaction, improving point-of-care operations, and enhancing sales performance. In addition, healthcare providers are focused on improving technological capabilities and developing head and neck cancer diagnostic methods that are compatible with remote access devices and mobile phone apps to quickly obtain accurate diagnostic results. Therefore, such factors are expected to drive the growth of the hospital segment in the global head and neck cancer diagnostic methods market during the forecast period.

Specialty clinics

A specialty clinic is a facility where patients are admitted for special research or treatment. Specialty clinics empower and energize the global head and neck cancer diagnostics market by advancing science and medical technology. The availability of advanced professionals such as nurse practitioners, clinical nurse specialists, physician assistants, and clinical pharmacists will increase the demand for specialized clinics in the global head and neck cancer diagnostics market during the forecast period.

Regional Analysis

For more insights about the market share of various regions View PDF Sample now!

North America is estimated to contribute 41% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The US is the largest contributor to the region. Many of the established market players in the head and neck cancer diagnostics market are headquartered in the US. This will make cancer diagnostic equipment widely available to address the increasing incidence of head and neck cancer in the US. Furthermore, the presence of established market players, increasing awareness about HPV-related diseases, and the presence of dedicated head and neck cancer treatment programs are expected to drive the growth of the regional head and neck cancer diagnostics market during the forecast period. 

COVID Recovery Analysis

The outbreak of COVID-19 negatively affected the healthcare systems regionally and also had a noteworthy impact on the head and neck cancer diagnostics market in 2020. However, in 2021, the initiation of large-scale vaccination drives?lifted the lockdown and travel restrictions, which led to the resumption of supply chain activities. Thus, such factors will increase the demand for head and neck cancer diagnostics in the region during the forecast period.

Buy Now Full Report and Discover More

Key Head and Neck Cancer Diagnostics Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

AbbVie Inc: The company offers head and neck cancer diagnostics such as ABBV 368 for the treatment of solid tumors such as triple negative breast cancer, non small cell lung cancer, ecurrent and metastatic, head and neck squamous cell carcinoma and many more.

  • Accuray Inc.
  • AdDent Inc.
  • Bristol Myers Squibb Co.
  • Canon Inc.
  • Carestream Health Inc.
  • Eli Lilly and Co.
  • Esaote Spa
  • Flexicare Group Ltd.
  • General Electric Co.
  • Hitachi Ltd.
  • KARL STORZ SE and Co. KG
  • Koninklijke Philips N.V.
  • Olympus Corp.
  • Optim LLC
  • Shimadzu Corp.
  • Siemens AG
  • Sumitomo Mitsui Financial Group
  • Xoran Technologies LLC
  • Merck KGaA

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Head and Neck Cancer Diagnostics Market: Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. 

Key Head and Neck Cancer Diagnostics Market Drivers

Increasing incidences of head and neck cancers is the key factor driving the growth of the market. Head and neck cancers include cancers of the oral cavity, throat (nasopharynx, oropharynx, and hypopharynx), larynx, sinuses, nasal cavities, and salivary glands. As of January 2020, head and neck cancer accounts for approximately 4% of all cancers in the US. In 2020, an estimated 562,328 people were diagnosed with head and neck cancer worldwide.

Furthermore, according to the NHS, around 12,000 people are newly diagnosed with head and neck cancer each year in the UK. Moreover, around 8,300 people are diagnosed with oral cancer each year in the UK, which equates to one in every 50 cancers diagnosed. Due to this high incidence of head and neck cancer, the demand for head and neck cancer diagnosis is expected to increase during the forecast period.

Significant Head and Neck Cancer Diagnostics Market Trends

The growing trend of oncology tourism is the primary trend shaping the market growth. Oncology treatment can be very costly. In the US, some diagnostic procedures and treatment courses can be very expensive. When people in the US travel to other countries for medical procedures, they save approximately 70 to 80 percent of the total costs incurred domestically, without compromising the quality of treatment or care. Another factor driving medical tourism is the fact that people diagnosed with or suspected of having cancer do not want to wait long for treatment.

Moreover, the most popular destinations for cancer treatment are Germany, Spain, France, India, and Israel. Germany offers superior technology-based treatments, France has the highest success rate in Europe, and Spain focuses on alternative oncology treatment options. Therefore, the growth trend in oncology tourism is expected to have a positive impact on the demand for cancer diagnostics, including the global head and neck cancer diagnostics market during the forecast period.

Major Head and Neck Cancer Diagnostics Market Challenges

The potential disadvantages of excise duty on the sale of medical devices is a challenge that affects the growth of the market. Excise taxes raise the price of a product below the full tax amount, and the price burden is shared by producers and consumers. This in turn will limit innovation. According to the Tax Foundation's general equilibrium model, the reinstatement of excise taxes could also cause significant job losses in the medical device industry.

Additionally, most hospitals in the US procure products from manufacturers through GPO at low prices. Therefore, hospitals' bargaining power may make it difficult for manufacturers to pass on the cost burden of this tax. If such tax policies are not abolished, they may pose major challenges to the growth of medical devices and impede the growth of the global head and neck cancer diagnostics market during the forecast period. 

Buy Now Full Report and Discover More

Key Head and Neck Cancer Diagnostics Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Head and Neck Cancer Diagnostics Market Customer Landscape

Segment Overview

The head and neck cancer diagnostics market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • Diagnostic Methods Outlook (USD Million, 2017 - 2027)
    • Biopsy and blood tests
    • Imaging
    • Endoscopy
    • Dental diagnostics
  • End-user Outlook (USD Million, 2017 - 2027)
    • Hospitals
    • Specialty clinics
    • Ambulatory surgical centers
    • Others
  • Region Outlook (USD Million, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of the World (ROW)
      • Australia 
      • Argentina
      • Brazil 

Head and Neck Cancer Diagnostics Market Scope

Report Coverage

Details

Page number

183

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 12.2%

Market growth 2023-2027

USD 4,937.16 million

Market structure

Fragmented

YoY growth 2022-2023(%)

11.02

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 41%

Key countries

US, Germany, France, China, and Japan

Competitive landscape

 Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

AbbVie Inc., Accuray Inc., AdDent Inc., Bristol Myers Squibb Co., Canon Inc., Carestream Health Inc., Eli Lilly and Co., Esaote Spa, Flexicare Group Ltd., General Electric Co., Hitachi Ltd., KARL STORZ SE and Co. KG, Koninklijke Philips N.V., Olympus Corp., Optim LLC, Shimadzu Corp., Siemens AG, Sumitomo Mitsui Financial Group, Xoran Technologies LLC, and Merck KGaA

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Head and Neck Cancer Diagnostics Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the head and neck cancer diagnostics market between 2023 and 2027
  • Precise estimation of the head and neck cancer diagnostics market size and its contribution to the market in focus on the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies' position and classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of head and neck cancer diagnostics market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Diagnostic Methods
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global head and neck cancer diagnostics market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on global head and neck cancer diagnostics market 2017 - 2021 ($ million)
    • 4.2 Diagnostic Methods Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Diagnostic Methods Segment 2017 - 2021 ($ million)
    • 4.3 End-user Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – End-user Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Diagnostic Methods

    • 6.1 Market segments
      • Exhibit 30: Chart on Diagnostic Methods - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Diagnostic Methods - Market share 2022-2027 (%)
    • 6.2 Comparison by Diagnostic Methods
      • Exhibit 32: Chart on Comparison by Diagnostic Methods
      • Exhibit 33: Data Table on Comparison by Diagnostic Methods
    • 6.3 Biopsy and blood tests - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Biopsy and blood tests - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Biopsy and blood tests - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Biopsy and blood tests - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Biopsy and blood tests - Year-over-year growth 2022-2027 (%)
    • 6.4 Imaging - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Imaging - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Imaging - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Imaging - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Imaging - Year-over-year growth 2022-2027 (%)
    • 6.5 Endoscopy - Market size and forecast 2022-2027
      • Exhibit 42: Chart on Endoscopy - Market size and forecast 2022-2027 ($ million)
      • Exhibit 43: Data Table on Endoscopy - Market size and forecast 2022-2027 ($ million)
      • Exhibit 44: Chart on Endoscopy - Year-over-year growth 2022-2027 (%)
      • Exhibit 45: Data Table on Endoscopy - Year-over-year growth 2022-2027 (%)
    • 6.6 Dental diagnostics - Market size and forecast 2022-2027
      • Exhibit 46: Chart on Dental diagnostics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 47: Data Table on Dental diagnostics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 48: Chart on Dental diagnostics - Year-over-year growth 2022-2027 (%)
      • Exhibit 49: Data Table on Dental diagnostics - Year-over-year growth 2022-2027 (%)
    • 6.7 Market opportunity by Diagnostic Methods
      • Exhibit 50: Market opportunity by Diagnostic Methods ($ million)
      • Exhibit 51: Data Table on Market opportunity by Diagnostic Methods ($ million)

    7 Market Segmentation by End-user

    • 7.1 Market segments
      • Exhibit 52: Chart on End-user - Market share 2022-2027 (%)
      • Exhibit 53: Data Table on End-user - Market share 2022-2027 (%)
    • 7.2 Comparison by End-user
      • Exhibit 54: Chart on Comparison by End-user
      • Exhibit 55: Data Table on Comparison by End-user
    • 7.3 Hospitals - Market size and forecast 2022-2027
      • Exhibit 56: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
      • Exhibit 57: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
      • Exhibit 58: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
      • Exhibit 59: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
    • 7.4 Specialty clinics - Market size and forecast 2022-2027
      • Exhibit 60: Chart on Specialty clinics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 61: Data Table on Specialty clinics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 62: Chart on Specialty clinics - Year-over-year growth 2022-2027 (%)
      • Exhibit 63: Data Table on Specialty clinics - Year-over-year growth 2022-2027 (%)
    • 7.5 Ambulatory surgical centers - Market size and forecast 2022-2027
      • Exhibit 64: Chart on Ambulatory surgical centers - Market size and forecast 2022-2027 ($ million)
      • Exhibit 65: Data Table on Ambulatory surgical centers - Market size and forecast 2022-2027 ($ million)
      • Exhibit 66: Chart on Ambulatory surgical centers - Year-over-year growth 2022-2027 (%)
      • Exhibit 67: Data Table on Ambulatory surgical centers - Year-over-year growth 2022-2027 (%)
    • 7.6 Others - Market size and forecast 2022-2027
      • Exhibit 68: Chart on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 69: Data Table on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 70: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 71: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 7.7 Market opportunity by End-user
      • Exhibit 72: Market opportunity by End-user ($ million)
      • Exhibit 73: Data Table on Market opportunity by End-user ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 75: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 76: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 77: Chart on Geographic comparison
      • Exhibit 78: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 79: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 80: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 81: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 83: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 84: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 85: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 87: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 88: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 89: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 95: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 96: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 97: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 Germany - Market size and forecast 2022-2027
      • Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.9 France - Market size and forecast 2022-2027
      • Exhibit 103: Chart on France - Market size and forecast 2022-2027 ($ million)
      • Exhibit 104: Data Table on France - Market size and forecast 2022-2027 ($ million)
      • Exhibit 105: Chart on France - Year-over-year growth 2022-2027 (%)
      • Exhibit 106: Data Table on France - Year-over-year growth 2022-2027 (%)
    • 9.10 China - Market size and forecast 2022-2027
      • Exhibit 107: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 108: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 109: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 110: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.11 Japan - Market size and forecast 2022-2027
      • Exhibit 111: Chart on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 112: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 113: Chart on Japan - Year-over-year growth 2022-2027 (%)
      • Exhibit 114: Data Table on Japan - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 115: Market opportunity by geography ($ million)
      • Exhibit 116: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 117: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 119: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 120: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 121: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 122: Matrix on vendor position and classification
            • 12.3 AbbVie Inc.
              • Exhibit 123: AbbVie Inc. - Overview
              • Exhibit 124: AbbVie Inc. - Product / Service
              • Exhibit 125: AbbVie Inc. - Key news
              • Exhibit 126: AbbVie Inc. - Key offerings
            • 12.4 Accuray Inc.
              • Exhibit 127: Accuray Inc. - Overview
              • Exhibit 128: Accuray Inc. - Product / Service
              • Exhibit 129: Accuray Inc. - Key news
              • Exhibit 130: Accuray Inc. - Key offerings
            • 12.5 Bristol Myers Squibb Co.
              • Exhibit 131: Bristol Myers Squibb Co. - Overview
              • Exhibit 132: Bristol Myers Squibb Co. - Product / Service
              • Exhibit 133: Bristol Myers Squibb Co. - Key news
              • Exhibit 134: Bristol Myers Squibb Co. - Key offerings
            • 12.6 Canon Inc.
              • Exhibit 135: Canon Inc. - Overview
              • Exhibit 136: Canon Inc. - Business segments
              • Exhibit 137: Canon Inc. - Key offerings
              • Exhibit 138: Canon Inc. - Segment focus
            • 12.7 Carestream Health Inc.
              • Exhibit 139: Carestream Health Inc. - Overview
              • Exhibit 140: Carestream Health Inc. - Product / Service
              • Exhibit 141: Carestream Health Inc. - Key offerings
            • 12.8 Esaote Spa
              • Exhibit 142: Esaote Spa - Overview
              • Exhibit 143: Esaote Spa - Product / Service
              • Exhibit 144: Esaote Spa - Key offerings
            • 12.9 General Electric Co.
              • Exhibit 145: General Electric Co. - Overview
              • Exhibit 146: General Electric Co. - Business segments
              • Exhibit 147: General Electric Co. - Key news
              • Exhibit 148: General Electric Co. - Key offerings
              • Exhibit 149: General Electric Co. - Segment focus
            • 12.10 Hitachi Ltd.
              • Exhibit 150: Hitachi Ltd. - Overview
              • Exhibit 151: Hitachi Ltd. - Business segments
              • Exhibit 152: Hitachi Ltd. - Key news
              • Exhibit 153: Hitachi Ltd. - Key offerings
              • Exhibit 154: Hitachi Ltd. - Segment focus
            • 12.11 KARL STORZ SE and Co. KG
              • Exhibit 155: KARL STORZ SE and Co. KG - Overview
              • Exhibit 156: KARL STORZ SE and Co. KG - Product / Service
              • Exhibit 157: KARL STORZ SE and Co. KG - Key news
              • Exhibit 158: KARL STORZ SE and Co. KG - Key offerings
            • 12.12 Koninklijke Philips N.V.
              • Exhibit 159: Koninklijke Philips N.V. - Overview
              • Exhibit 160: Koninklijke Philips N.V. - Business segments
              • Exhibit 161: Koninklijke Philips N.V. - Key news
              • Exhibit 162: Koninklijke Philips N.V. - Key offerings
              • Exhibit 163: Koninklijke Philips N.V. - Segment focus
            • 12.13 Merck KGaA
              • Exhibit 164: Merck KGaA - Overview
              • Exhibit 165: Merck KGaA - Business segments
              • Exhibit 166: Merck KGaA - Key news
              • Exhibit 167: Merck KGaA - Key offerings
              • Exhibit 168: Merck KGaA - Segment focus
            • 12.14 Optim LLC
              • Exhibit 169: Optim LLC - Overview
              • Exhibit 170: Optim LLC - Product / Service
              • Exhibit 171: Optim LLC - Key offerings
            • 12.15 Shimadzu Corp.
              • Exhibit 172: Shimadzu Corp. - Overview
              • Exhibit 173: Shimadzu Corp. - Business segments
              • Exhibit 174: Shimadzu Corp. - Key news
              • Exhibit 175: Shimadzu Corp. - Key offerings
              • Exhibit 176: Shimadzu Corp. - Segment focus
            • 12.16 Siemens AG
              • Exhibit 177: Siemens AG - Overview
              • Exhibit 178: Siemens AG - Business segments
              • Exhibit 179: Siemens AG - Key news
              • Exhibit 180: Siemens AG - Key offerings
              • Exhibit 181: Siemens AG - Segment focus
            • 12.17 Xoran Technologies LLC
              • Exhibit 182: Xoran Technologies LLC - Overview
              • Exhibit 183: Xoran Technologies LLC - Product / Service
              • Exhibit 184: Xoran Technologies LLC - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 185: Inclusions checklist
                • Exhibit 186: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 187: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 188: Research methodology
                • Exhibit 189: Validation techniques employed for market sizing
                • Exhibit 190: Information sources
              • 13.5 List of abbreviations
                • Exhibit 191: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              head and neck cancer diagnostics market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis